Zyrtec-d 12 Hour
Drug - Zyrtec-d 12 Hour
The trade name of the product as shown on the labeling.
Dosage -
TABLET, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride
Multiple ingredients are in alphabetical order.
Strength -
5MG;120MG
The potency of the active ingredient(s), Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride. May repeat for multiple part products.
Applicant -
PFIZER
The firm name holding legal responsibility for Zyrtec-d 12 Hour. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
021150
The FDA assigned number to Zyrtec-d 12 Hour. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Zyrtec-d 12 Hour. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Aug 10, 2001
The date Zyrtec-d 12 Hour was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
Yes
The pioneer or innovator of Zyrtec-d 12 Hour. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Zyrtec-d 12 Hour is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Pfizer Inc
The full name of the firm holding legal responsibility for the new application of Zyrtec-d 12 Hour.
Zyrtec-d 12 Hour
|
